A major portion of a company's value derives from intangible assets such as brand equity, but threats to brands have grown with the proliferation of online pharmacies and user-generated content. Estimates of annual global sales of counterfeit medicines range from $35 billion to $75 billion and the prevalence of this issue is only expected to expand as the Internet grows as a popular source of health information. A non-integrated brand protection program poses significant risks to a company including: compromised safety and efficacy, decline in intangible asset value, cost increases and revenue loss.
This brief from PwC offers an overview of this growing issue and a 4 step process to implement your own brand protection program.
Look for papers, articles, and case studies. See all thought leadership.